NCT06327776View on ClinicalTrials.gov

New Protein Biomarkers and Technology for Improving Diagnosis and Outcome Prediction in Mild TBI

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

March 4, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions
Mild Traumatic Brain Injury
Interventions
OTHER

Serum and saliva biomarkers

2x5mL blood samples and saliva samples will be used to determine the performance of different blood based and saliva biomarkers for determining diagnostic management and prognosis in mTBI patients.

Trial Locations (1)

28041

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

All Listed Sponsors
lead

Hospital Universitario 12 de Octubre

OTHER